Archives
-
Diethylmaleate in GST and Oxidative Stress Assays
2026-09-24
Use Diethylmaleate to test whether glutathione-linked defenses help insects withstand pesticide stress, while separating GST effects from broader changes in redox state. A practical workflow pairs dose-finding with GSH, GST, antioxidant-capacity, and insecticide-response measurements.
-
GST Antioxidant Defense in Thrips Insecticide Resistance
2026-09-24
Dong and colleagues provide functional evidence that glutathione S-transferase activity helps Megalurothrips usitatus withstand lambda-cyhalothrin by supporting antioxidant defenses. Inhibition with diethyl maleate lowered antioxidant capacity and increased insecticide sensitivity, connecting a redox response to the resistance phenotype while leaving questions about GST-specific mechanisms open.
-
IWP-L6: A Potent Porcupine Inhibitor for Wnt Studies
2026-09-23
IWP-L6 is a Porcupine inhibitor reported to block Porcn-mediated Wnt protein palmitoylation, with a listed potency value of 0.5 nM. This article distinguishes product benchmarks from peer-reviewed evidence on Wnt-regulated bone metabolism and outlines practical ways to test Wnt signaling modulation without treating the two evidence streams as interchangeable.
-
CKI 7 Dihydrochloride: CK1 Assay Workflow
2026-09-23
Build cleaner Casein kinase 1 perturbation experiments with a controlled dosing, vehicle-matched workflow for Wnt, circadian, DNA-repair, and cancer models. The guide also shows how to use CKI 7 dihydrochloride alongside, but not as a substitute for, mechanistic evidence from the MAPK10–KRT16 metastasis axis.
-
Intravesical p21 mRNA–LNP Therapy in Bladder Cancer
2026-09-22
A 2026 FASEB Journal study developed chemically modified p21 mRNA–loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, inhibited tumor-cell proliferation, and reduced orthotopic tumor growth while producing strong bladder-localized expression with limited systemic distribution.
-
TBST Workflows for uPAR·uPA Assay Rigor
2026-09-22
TBST helps convert antibody-based measurements into cleaner, more interpretable evidence across Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. This practical guide connects buffer control with the conformation-aware uPAR·uPA inhibitor study while separating assay quality from claims of therapeutic efficacy.
-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-09-21
The reference review presents dabigatran etexilate as a major advance in anticoagulation: an orally absorbed prodrug that produces rapid, predictable, reversible direct thrombin inhibition without cytochrome P450-dependent activation or metabolism. Its clinical value lies in reducing reliance on routine warfarin-style monitoring, while renal function, bleeding risk, gastrointestinal tolerability, and patient selection remain central to safe use.
-
Cy5 TSA Fluorescence System Kit for Liver Imaging
2026-09-21
The Cy5 TSA Fluorescence System Kit converts localized HRP activity into a bright far-red signal for challenging IHC, ICC, and FISH experiments. Its strongest use case is resolving rare or immature liver cell populations, where conventional fluorescence may miss low-abundance targets or fine tissue boundaries.
-
12-O-tetradecanoyl phorbol-13-acetate Workflow
2026-09-20
Build reproducible ERK/MAPK and protein kinase C signaling experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from acute phospho-ERK assays to skin cancer models. This guide connects practical dosing, time-course design, co-culture controls, and troubleshooting to findings from papillary thyroid carcinoma and macrophage-polarization research.
-
Carvedilol: Selectivity as a Regeneration Variable
2026-09-19
Carvedilol is a β-adrenergic receptor antagonist whose effects extend beyond cardiovascular signaling. This article explains how receptor selectivity, injury state, redox biology, and assay timing reshape its use in vascular and hematopoietic research.
-
Trim71–Ago2 Control of ESC Pluripotency via let-7
2026-09-18
Liu et al. show that the RNA-binding protein Trim71 maintains mouse embryonic stem cell pluripotency by repressing Ago2 mRNA translation, thereby limiting maturation of the pro-differentiation let-7 microRNAs. The study provides a mechanistic explanation for the proposed Trim71–let-7 bistable switch and highlights mature microRNA availability as a cytoplasmic control point in stem cell fate.
-
Diclofenac in Organoid Pharmacokinetic Research
2026-09-18
Diclofenac is a non-selective COX inhibitor that suppresses prostaglandin production and supports inflammation signaling pathway studies. Human iPSC-derived intestinal organoids add a human-relevant platform for evaluating compound metabolism, transport, and pharmacokinetic behavior.
-
Separating Growth Inhibition from Cancer Cell Killing
2026-09-17
Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a response-analysis framework that separates proliferative arrest from cell death and accounts for their different magnitudes and timing, improving interpretation of in vitro drug experiments.
-
Stattic as a Precision Tool for STAT3 Assays
2026-09-17
Stattic is a selective STAT3 inhibitor for dissecting transcriptional signaling, apoptosis, and radiosensitivity. This article presents an assay-centered framework that connects HNSCC models with new mechanistic insights from the STING–STAT3–autophagy axis in psoriasis research.
-
HMGCS2, LysoPC, and Pulmonary Fibrosis
2026-09-16
Yang et al. identify injured alveolar type II epithelial cells as a major source of accumulated lysophosphatidylcholine in experimental pulmonary fibrosis and connect this lipid change to fibroblast activation. Their data support an AECII HMGCS2–PPARα–CPT1A/CPT2 axis that promotes lipid degradation and attenuates fibrotic disease, providing a mechanistic framework for lipid-focused intervention studies.